We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$268B
AUM Growth
+$45.9B
Cap. Flow
+$30.5B
Cap. Flow %
11.36%
Top 10 Hldgs %
29.82%
Holding
5,008
New
209
Increased
2,223
Reduced
1,248
Closed
867

Sector Composition

Rank Sector Weight
1 Technology 14.97%
2 Financials 8.75%
3 Healthcare 7.15%
4 Consumer Discretionary 6.46%
5 Communication Services 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFC
3476
DELISTED
China Life Insurance Company Ltd.
LFC
$230K ﹤0.01%
27,975
MRLN
3477
DELISTED
Marlin Business Services Corp
MRLN
$230K ﹤0.01%
9,855
-38,713
-80% -$883K
ARKF icon
3478
ARK Blockchain & Fintech Innovation ETF
ARKF
$726M
$229K ﹤0.01%
5,605
-36,189
-87% -$1.74M
SPXL icon
3479
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.7B
$229K ﹤0.01%
1,600
TCRR
3480
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$229K ﹤0.01%
49,071
+16,039
+49% +$100K
CNQ icon
3481
CALL
Canadian Natural Resources
CNQ
$99.3B
$228K ﹤0.01%
+11,027
New +$223K
SYRS
3482
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$228K ﹤0.01%
6,988
+2,502
+56% +$101K
ATOS icon
3483
Atossa Therapeutics
ATOS
$21.2M
$227K ﹤0.01%
9,467
+6,280
+197% +$230K
FBIO icon
3484
Fortress Biotech
FBIO
$104M
$226K ﹤0.01%
6,023
+3,732
+163% +$166K
VMD icon
3485
Viemed Healthcare
VMD
$446M
$225K ﹤0.01%
42,974
+28,504
+197% +$159K
BFX
3486
DELISTED
BowFlex Inc.
BFX
$225K ﹤0.01%
36,577
+12,062
+49% +$100K
CBAN icon
3487
Colony Bankcorp
CBAN
$462M
$224K ﹤0.01%
13,125
-918
-7% -$16.7K
DLTH icon
3488
Duluth Holdings
DLTH
$155M
$224K ﹤0.01%
14,738
+9,179
+165% +$139K
EVLO
3489
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$224K ﹤0.01%
1,843
+1,222
+197% +$206K
MAC icon
3490
PUT
Macerich
MAC
$7.29B
$223K ﹤0.01%
12,900
GENC icon
3491
Gencor Industries
GENC
$209M
$222K ﹤0.01%
19,269
-1,238
-6% -$14.3K
HMTV
3492
DELISTED
Hemisphere Media Group, Inc.
HMTV
$220K ﹤0.01%
30,274
+13,031
+76% +$127K
BCYC
3493
Bicycle Therapeutics
BCYC
$269M
$219K ﹤0.01%
3,600
-2,522
-41% -$139K
EBMT icon
3494
Eagle Bancorp Montana
EBMT
$188M
$219K ﹤0.01%
9,526
-772
-7% -$17.4K
OEF icon
3495
iShares S&P 100 ETF
OEF
$20.1B
$219K ﹤0.01%
1,000
-334
-25% -$70.8K
PKOH icon
3496
Park-Ohio Holdings
PKOH
$574M
$219K ﹤0.01%
10,324
+6,847
+197% +$155K
CALB
3497
DELISTED
California BanCorp Common Stock
CALB
$219K ﹤0.01%
10,321
-1,196
-10% -$22.4K
RSX
3498
CALL
DELISTED
VanEck Russia ETF
RSX
$219K ﹤0.01%
8,200
FIS icon
3499
PUT
Fidelity National Information Services
FIS
$23.2B
$218K ﹤0.01%
2,000
UBFO
3500
DELISTED
United Security Bancshares
UBFO
$218K ﹤0.01%
26,904
-1,853
-6% -$14.8K

Similar funds

Barclays's Q4 2021 Portfolio in Review

As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.

  • Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
  • Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
  • Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
  • Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
  • Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
  • Barclays opened 209 new positions and closed 867 in Q4 2021.
  • Barclays's portfolio value rose 21% quarter-over-quarter to $268B.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.